ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 137765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 137765; 2) Community: the network communities that were significantly associated with the response to NSC 137765; 3) Molecule: the relationships between components within communities and NSC 137765; 4) MDR: the compounds that were significantly associated with the NSC 137765.

NSC Compound Enrichment Correlation
NSC 222722 Null 0.0162638908166157 -0.05293503
NSC 236580 .beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone 0.0162638908166157 0.35259314
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0162638908166157 0.47444374
NSC 53861 Null 0.0162638908166157 0.23675854
NSC 605607 Null 0.0162638908166157 0.033235262
NSC 634766 Null 0.0162638908166157 0.027753851
NSC 642704 S-N-(Phenethylthiocarbamoyl)-L-glutathione 0.0162638908166157 0.092195613
NSC 648365 Insulin-Methotrexate conjugate 0.0162638908166157 0.41585323
NSC 661229 Null 0.0162638908166157 0.071920516
NSC 665484 Null 0.0162638908166157 0.38638796
Total:149  Current:69    [First] [Prev] [Next] [Last]